4.22
price up icon4.98%   0.20
after-market 시간 외 거래: 4.43 0.21 +4.98%
loading
전일 마감가:
$4.02
열려 있는:
$4.03
하루 거래량:
663.29K
Relative Volume:
0.67
시가총액:
$153.01M
수익:
-
순이익/손실:
$-86.60M
주가수익비율:
-1.4899
EPS:
-2.8324
순현금흐름:
$-67.37M
1주 성능:
+0.24%
1개월 성능:
+55.15%
6개월 성능:
-35.87%
1년 성능:
-72.97%
1일 변동 폭
Value
$3.91
$4.465
1주일 범위
Value
$3.91
$4.495
52주 변동 폭
Value
$1.45
$19.50

Lexeo Therapeutics Inc Stock (LXEO) Company Profile

Name
명칭
Lexeo Therapeutics Inc
Name
전화
(212) 547-9879
Name
주소
345 PARK AVENUE SOUTH, NEW YORK
Name
직원
75
Name
트위터
Name
다음 수익 날짜
2025-03-24
Name
최신 SEC 제출 서류
Name
LXEO's Discussions on Twitter

LXEO을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
LXEO
Lexeo Therapeutics Inc
4.22 153.01M 0 -86.60M -67.37M -2.8324
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.16 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
534.91 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.06 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
542.47 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.16 28.51B 3.81B -644.79M -669.77M -6.24

Lexeo Therapeutics Inc Stock (LXEO) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-06-13 개시 Robert W. Baird Outperform
2024-06-06 개시 H.C. Wainwright Buy
2023-11-28 개시 Chardan Capital Markets Buy
2023-11-28 개시 JP Morgan Overweight
2023-11-28 개시 Leerink Partners Outperform
2023-11-28 개시 RBC Capital Mkts Outperform
2023-11-28 개시 Stifel Buy
모두보기

Lexeo Therapeutics Inc 주식(LXEO)의 최신 뉴스

pulisher
Jun 16, 2025

Bank of America Corp DE Trims Stock Position in Lexeo Therapeutics, Inc. (NASDAQ:LXEO) - Defense World

Jun 16, 2025
pulisher
Jun 14, 2025

Lexeo Therapeutics files to sell 41.63M shares of common stock for holders - MSN

Jun 14, 2025
pulisher
Jun 14, 2025

Lexeo Therapeutics (LXEO) Proposes Sale of 41.63 Million Shares - GuruFocus

Jun 14, 2025
pulisher
Jun 13, 2025

Lexeo Therapeutics Registers Share Offering on Behalf of Selling Stockholders - MarketScreener

Jun 13, 2025
pulisher
Jun 13, 2025

Lexeo Therapeutics (LXEO) Proposes Sale of 41.63 Million Shares | LXEO Stock News - GuruFocus

Jun 13, 2025
pulisher
Jun 08, 2025

Jane Street Group LLC Reduces Stock Position in Lexeo Therapeutics, Inc. (NASDAQ:LXEO) - Defense World

Jun 08, 2025
pulisher
Jun 08, 2025

Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Stake Lifted by Wellington Management Group LLP - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Shares Acquired by Millennium Management LLC - Defense World

Jun 06, 2025
pulisher
Jun 04, 2025

Deutsche Bank AG Buys 8,378 Shares of Lexeo Therapeutics, Inc. (NASDAQ:LXEO) - Defense World

Jun 04, 2025
pulisher
Jun 02, 2025

Wilson Sonsini Advises Lexeo Therapeutics on $80 Million Private Placement Equity Financing - Wilson Sonsini

Jun 02, 2025
pulisher
May 31, 2025

Lexeo Therapeutics (NASDAQ:LXEO) Given New $10.00 Price Target at JPMorgan Chase & Co. - Defense World

May 31, 2025
pulisher
May 31, 2025

Leerink Partnrs Issues Optimistic Outlook for LXEO Earnings - Defense World

May 31, 2025
pulisher
May 30, 2025

Lexeo Therapeutics (LXEO) Price Target Lowered by JP Morgan | LX - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Lexeo Therapeutics (LXEO) Price Target Lowered by JP Morgan | LXEO Stock News - GuruFocus

May 30, 2025
pulisher
May 29, 2025

BNP Paribas Financial Markets Buys 28,986 Shares of Lexeo Therapeutics, Inc. (NASDAQ:LXEO) - Defense World

May 29, 2025
pulisher
May 28, 2025

Northern Trust Corp Acquires 14,185 Shares of Lexeo Therapeutics, Inc. (NASDAQ:LXEO) - Defense World

May 28, 2025
pulisher
May 28, 2025

Lexeo raises $80 million to shore up gene therapy work after layoffs - The Pharma Letter

May 28, 2025
pulisher
May 27, 2025

Leerink cuts Lexeo Therapeutics price target to $10, maintains outlook - Investing.com Australia

May 27, 2025
pulisher
May 27, 2025

Leerink cuts Lexeo Therapeutics price target to $10, maintains outlook By Investing.com - Investing.com India

May 27, 2025
pulisher
May 27, 2025

Lexeo Therapeutics raises $80M in private placement (LXEO) - Seeking Alpha

May 27, 2025
pulisher
May 27, 2025

Lexeo Therapeutics secures $80 million in private placement By Investing.com - Investing.com South Africa

May 27, 2025
pulisher
May 27, 2025

Lexeo Therapeutics (LXEO) Secures $80M from Private Placement | - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Lexeo Therapeutics Announces $80 Mln Private Placement Of Shares - Nasdaq

May 27, 2025
pulisher
May 27, 2025

Lexeo Therapeutics Announces $80 Million Equity Financing - marketscreener.com

May 27, 2025
pulisher
May 27, 2025

Lexeo prices 20.8M shares at $2.8825 in private placement - TipRanks

May 27, 2025
pulisher
May 27, 2025

Lexeo Therapeutics Announces $80M Private Placement Agreement - TipRanks

May 27, 2025
pulisher
May 27, 2025

Lexeo Therapeutics (LXEO) Secures $80M from Private Placement | LXEO Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Lexeo Therapeutics secures $80 million in private placement - Investing.com

May 27, 2025
pulisher
May 27, 2025

Lexeo Therapeutics Announces $80 Million Equity Financing to Further Advance Development of Transformative Genetic Medicines for Cardiovascular Diseases - The Manila Times

May 27, 2025
pulisher
May 27, 2025

Lexeo Therapeutics Secures $80 Million Financing to Extend Cash Runway into 2028 for Clinical Programs - Nasdaq

May 27, 2025
pulisher
May 27, 2025

Lexeo Therapeutics Announces $80 Million Equity Financing to Further Advance Development of ... - Bluefield Daily Telegraph

May 27, 2025
pulisher
May 27, 2025

Major Investors Back Lexeo Therapeutics with $80M for Breakthrough Genetic Heart Disease Programs - Stock Titan

May 27, 2025
pulisher
May 22, 2025

Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Given Average Rating of “Buy” by Brokerages - Defense World

May 22, 2025
pulisher
May 19, 2025

Price T Rowe Associates Inc. MD Acquires New Position in Lexeo Therapeutics, Inc. (NASDAQ:LXEO) - Defense World

May 19, 2025
pulisher
May 19, 2025

Q1 Earnings Forecast for LXEO Issued By HC Wainwright - Defense World

May 19, 2025
pulisher
May 18, 2025

FY2025 Earnings Forecast for LXEO Issued By Chardan Capital - Defense World

May 18, 2025
pulisher
May 18, 2025

HC Wainwright Lowers Lexeo Therapeutics (NASDAQ:LXEO) Price Target to $15.00 - Defense World

May 18, 2025
pulisher
May 16, 2025

Lexeo stock price target cut to $15 by H.C. Wainwright - Investing.com South Africa

May 16, 2025
pulisher
May 16, 2025

Lexeo Therapeutics price target lowered to $15 from $23 at H.C. Wainwright - TipRanks

May 16, 2025
pulisher
May 16, 2025

Lexeo Therapeutics, Inc.: Promising Gene Therapy Advancements and Superior Safety Profile Drive Buy Rating - TipRanks

May 16, 2025
pulisher
May 16, 2025

#ASGCT25: In three patients, Rocket’s second heart gene therapy shows promise - Endpoints News

May 16, 2025
pulisher
May 16, 2025

Lexeo Therapeutics (LXEO) Analyst Rating Update and Price Target Adjustment | LXEO Stock News - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Lexeo Therapeutics (LXEO) Price Target Cut to $15 by H.C. Wainwr - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Leerink Partnrs Has Bearish Forecast for LXEO Q2 Earnings - Defense World

May 16, 2025
pulisher
May 15, 2025

Chardan Capital Has Lowered Expectations for Lexeo Therapeutics (NASDAQ:LXEO) Stock Price - Defense World

May 15, 2025
pulisher
May 14, 2025

Lexeo Therapeutics: Strategic Focus and Promising Pipeline Drive Buy Rating - TipRanks

May 14, 2025
pulisher
May 13, 2025

Lexeo Therapeutics (LXEO) Sees Price Target Adjustment by Charda - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Chardan Adjusts Price Target on Lexeo Therapeutics to $20 From $22, Maintains Buy Rating - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Lexeo Therapeutics Reports Increased Losses Amid R&D Expansion - TipRanks

May 13, 2025
pulisher
May 12, 2025

Lexeo Therapeutics price target lowered to $20 from $22 at Chardan - TipRanks

May 12, 2025

Lexeo Therapeutics Inc (LXEO) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Lexeo Therapeutics Inc 주식 (LXEO) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Adler Eric
Chief Medical Officer
May 16 '25
Sale
2.77
585
1,623
67,681
Robertson Jenny
Chief Legal Officer
May 16 '25
Sale
2.77
521
1,445
63,098
See Tai Sandi
Chief Development Officer
May 16 '25
Sale
2.77
367
1,018
59,242
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
자본화:     |  볼륨(24시간):